Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - IMMUNIC, INC. | vtl-123117xexhibit311a.htm |
| EX-31.2 - EXHIBIT 31.2 - IMMUNIC, INC. | vtl-123117xexhibit312a.htm |
| 10-K/A - 10-K/A - IMMUNIC, INC. | vtl-123117x10ka.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-204097) and Registration Statements on Form S-8 (Nos. 333-196571, 333-204644, 333-211359, 333-218298 and 333-222886) of Vital Therapies, Inc. of our report dated March 13, 2018 relating to the financial statements, which appears in Vital Therapies, Inc.'s Annual Report on Form 10-K for the year-ended December 31, 2017.
/s/ PricewaterhouseCoopers LLP |
PricewaterhouseCoopers LLP |
San Diego, California |
March 13, 2018 |